as related to Cannabiz way Co., Ltd and CBD Bioscience Co., Ltd that would impact on the consolidated financial statements and the separate financial statements. Therefore, the SEC has notified EE (1
Analysis Yearly Ending 31 December 2018 Highlights In 2018, the Company and subsidiary’s total net loss equals Baht 2,358 million comparing with last year which has net profit Baht 366 million. Separate
increase however raw material cost and cash conversion cost also high, therefore, result in net loss. Separate financial statement, the Company has net loss Baht 192 million, decreased in net loss comparing
Medical Business Plc., (CMR) amount Baht 1,010.31 million. comparing at the same period in 2017 representing 18.19% increase. Income from medical treatments in the separate financial went up 17.07% due to
Chiang Mai Ram Medical Business Plc., (CMR) amount Baht 995.22 million comparing at the same period in 2018 representing 1.86% increase . Income from medical treatments in the separate financial went up
ended September 30, 2019 To The President and Director The Stock Exchange of Thailand Dear Sirs, Finansia Syrus Securities Public Company would like to disclose the reviewed consolidated and separate
Medical Business Plc., (CMR) amount Baht 854.83 million. comparing at the same period in 2016 representing 3.30% increase. Income from medical treatments in the separate financial went down 3.46% due to the
Medical Business Pcl., (CMR) amount Baht 872.11 million. comparing at the same period in 2016 representing 8.11% increase. Income from medical treatments in the separate financial went up 4.19% due to the
Chiang Mai Ram Medical Business Pcl., (CMR) amount Baht 1,035.05 million. comparing at the same period in 2016 representing 11.98% increase. Income from medical treatments in the separate financial went up
million . Income from medical treatments in the separate financial went down 1.22% due to the increased in the number of out-patients to 1.09% but the number of in-patients decreased 10.68 %. The rental and